DrFirst Announces 2024 Healthiverse Heroes Award Winners

DrFirst Announces 2024 Healthiverse Heroes Award Winners https://www.prnewswire.com/news-releases/drfirst-announces-2024-healthiverse-heroes-award-winners-302150945.html?tc=eml_cleartime

CG Life Acquires Berry & Company Public Relations, Further Expanding Strategic Communications Services for BioPharma and Healthcare

CG Life, a science-first, tech-enabled agency, acquires Berry & Company Public Relations. The acquisition significantly expands the range of CG Life communications expertise and services to support clients in the biopharma and medical sectors.

Huateng Pharma Introduces Piroctone Olamine: A New Solution for Fungal Infections and Dandruff Control

Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).

Biopharma PEG to Showcase Innovative PEG Derivatives at BIO 2024 in San Diego

Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.

Lindus Health Announces Cosmetics Clinical Trial with Acinonyx Bio to Evaluate an Alternative to Benzoyl Peroxide for Inflammatory Acne

https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime

IntelliGuard Appoints Seasoned Leader as New Chief Product Officer for Enhanced Healthcare Solutions

Rob Sobie to support IntelliGuard’s ongoing innovation to track, trace, and improve safety in medication inventory

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

Precision medicine biotechnology company for obesity secures additional institutional capital from prominent industry leaders to expand the use of its novel phenotyping test and advance clinical research in weight loss treatment.

MDClone Earns Fourth Consecutive "Best Healthcare Big Data Platform" Award from MedTech Breakthrough

https://www.prnewswire.com/news-releases/mdclone-earns-fourth-consecutive-best-healthcare-big-data-platform-award-from-medtech-breakthrough-302147956.html?tc=eml_cleartime

Prebiotic Fibre Supplement Significantly Reduces Risk of Developing Type 2 Diabetes, UK Study Finds

Today, The British Journal of Nutrition published a study that found the consumption of a daily prebiotic fibre supplement helped to improve insulin sensitivity and other important health markers in patients with pre-diabetes

Alfa Chemistry Debuts Shape Memory Alloys, Nitinol SMAs, and 3D Printing Alloys

Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

Integrated DNA Technologies and Molecular Health Ink Commercial Partnership

IDT and Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their NGS capabilities.

Icosagen and Lead Discovery Center Announce Collaboration to Discover Novel Monoclonal Antibodies

Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.

Inceptua Group Expands Early Access Program to Latin America

Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.

Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers

Vector Laboratories joins forces with Absolute Biotech, bolstering its role as a key manufacturer for life science customers, enriching its antibody reagents portfolio, and expanding its commercial presence into the UK and EU.

Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform

Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.

PrecisionLife and Metrodora Institute Launch Clinical Trials to Accelerate the Diagnosis and Treatment of ME/CFS and Long Covid Patients

Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.

ZeOmega Supports Health Plan Alliance with Payvider Solutions 

Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing

Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.

Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer

Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer